Clinical investigation in duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural history

作者: Michael H. Brooke , Gerald M. Fenichel , Robert C. Griggs , Jerry R. Mendell , Richard Moxley

DOI: 10.1002/MUS.880060204

关键词:

摘要: A prospective study of 114 patients with DMD provided data for "power" calculations future therapeutic trials. There was a decline in strength 0.4 units per year (on 0-10 scale). Contractures the iliotibial bands, hip flexors, and heel cords developed before 6 years. other joints accompanied increased use wheelchairs. All children walked until 8 years functional "improvement" between 3-6 Children same age varied widely their strength, degree contracture, abilities. Fifteen percent appear to have milder variety disease are termed "outliers." To test drug which might slow 25% its original rate progression, two groups (placebo treatment) 40 each would be followed one year.

参考文章(11)
James E. Carroll, James E. Carroll, Julaine M. Florence, Michael H. Brooke, Michael H. Brooke, Evaluation of the child with muscular weakness. Orthopedic Clinics of North America. ,vol. 9, pp. 409- 430 ,(1978) , 10.1016/S0030-5898(20)30658-1
Richard L. Goldstein, Richard W. Hyde, Lowell W. Lapham, Kuddusi Gazioglu, Zsolt G. DePapp, Peripheral neuropathy presenting with respiratory insufficiency as the primary complaint The American Journal of Medicine. ,vol. 56, pp. 443- 449 ,(1974) , 10.1016/0002-9343(74)90474-4
Paul J. Vignos, Management of Progressive Muscular Dystrophy of Childhood JAMA: The Journal of the American Medical Association. ,vol. 184, pp. 89- 96 ,(1963) , 10.1001/JAMA.1963.03700150043007
Michael H. Brooke, Robert C. Griggs, Jerry R. Mendell, Gerald M. Fenichel, Jack B. Shumate, Richard J. Pellegrino, Clinical trial in duchenne dystrophy. I. The design of the protocol Muscle & Nerve. ,vol. 4, pp. 186- 197 ,(1981) , 10.1002/MUS.880040304
Scott R. Inkley, Frederick C. Oldenburg, Paul J. Vignos, Pulmonary function in Duchenne muscular dystrophy related to stage of disease The American Journal of Medicine. ,vol. 56, pp. 297- 306 ,(1974) , 10.1016/0002-9343(74)90611-1
F. A. ZITER, K. G. ALLSOP, F. H. TYLER, Assessment of muscle strength in Duchenne muscular dystrophy. Neurology. ,vol. 27, pp. 981- 981 ,(1977) , 10.1212/WNL.27.10.981
R. C. Griggs, K. M. Donohoe, M. J. Utell, D. Goldblatt, R. T. Moxley, Evaluation of pulmonary function in neuromuscular disease JAMA Neurology. ,vol. 38, pp. 9- 12 ,(1981) , 10.1001/ARCHNEUR.1981.00510010035004
V DUBOWITZ, J HECKMATT, MANAGEMENT OF MUSCULAR DYSTROPHY: Pharmacological and Physical Aspects British Medical Bulletin. ,vol. 36, pp. 139- 144 ,(1980) , 10.1093/OXFORDJOURNALS.BMB.A071629
Jacob Cohen, CHAPTER 10 – Technical Appendix: Computational Procedures Statistical Power Analysis for the Behavioral Sciences (Revised Edition). pp. 455- 463 ,(1977) , 10.1016/B978-0-12-179060-8.50015-3